We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BUPRENORPHINE JUNO; BUPRENORPHINE JN; BUPRESPAN; BUPRENORPHINE DB (Juno Pharmaceuticals Pty Ltd)
Product name
BUPRENORPHINE JUNO; BUPRENORPHINE JN; BUPRESPAN; BUPRENORPHINE DB
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
210 (255 working days)
Active ingredients
buprenorphine
Registration type
New generic medicine
Indication
BUPRENORPHINE JUNO; BUPRENORPHINE JN; BUPRESPAN; BUPRENORPHINE DB (transdermal drug delivery system) is indicated for the management of moderate to severe pain